Quan Capital: A venture capital firm incubating next-gen life sciences companies for healthcare solutions.
Location
Shanghai, CN
Founded
2017
Quan Capital is a venture capital firm focused on discovering, incubating, and growing next-generation life sciences companies that address critical healthcare challenges. They typically invest in Series A and Series B rounds, with occasional participation in later stages. Their portfolio companies are at the forefront of developing breakthrough therapies and cutting-edge technologies aimed at generating significant value for patients.
Notable portfolio companies include Adcentrx Therapeutics, Centrexion Therapeutics, Citrine Medicine, Interius BioTherapeutics, Kira Pharmaceuticals, NextCure, Tempest Therapeutics, Walking Fish Therapeutics, and Zenas BioPharma. Quan Capital's investment philosophy emphasizes exploring disruptive solutions within the healthcare sector. They offer unique value-add services to their portfolio companies, leveraging their deep industry expertise and extensive network to foster innovation and growth.
Quan Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages